These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18522242)

  • 1. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
    Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
    Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR
    Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice.
    Stahl T; Reimers C; Johne R; Schliebs R; Seeger J
    Eur J Neurosci; 2006 Oct; 24(7):1923-34. PubMed ID: 17067295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
    Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model.
    Gaspar RC; Villarreal SA; Bowles N; Hepler RW; Joyce JG; Shughrue PJ
    Exp Neurol; 2010 Jun; 223(2):394-400. PubMed ID: 19744481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
    Dolev I; Michaelson DM
    Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice.
    Seabrook TJ; Jiang L; Maier M; Lemere CA
    Glia; 2006 May; 53(7):776-82. PubMed ID: 16534778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
    Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging brain amyloid of Alzheimer disease in vivo in transgenic mice with an Abeta peptide radiopharmaceutical.
    Lee HJ; Zhang Y; Zhu C; Duff K; Pardridge WM
    J Cereb Blood Flow Metab; 2002 Feb; 22(2):223-31. PubMed ID: 11823720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.
    Damjanac M; Rioux Bilan A; Barrier L; Pontcharraud R; Anne C; Hugon J; Page G
    Brain Res; 2007 Jan; 1128(1):40-9. PubMed ID: 17125750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intraneuronal Abeta deposition in the hippocampus of APP transgenic mice.
    Shie FS; LeBoeuf RC; Jin LW
    Neuroreport; 2003 Jan; 14(1):123-9. PubMed ID: 12544843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.
    Lee JY; Friedman JE; Angel I; Kozak A; Koh JY
    Neurobiol Aging; 2004; 25(10):1315-21. PubMed ID: 15465629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
    Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
    Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.
    Wyss-Coray T; Lin C; Yan F; Yu GQ; Rohde M; McConlogue L; Masliah E; Mucke L
    Nat Med; 2001 May; 7(5):612-8. PubMed ID: 11329064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.